Výsledky vyhledávání

Compliance (COMP) with colon cancer (CoC) national guidelines (NG) for chemotherapy (CT) by implementing electronic medical records (EMR)

Autor: R. C. Horns, W. McNatt, Linda D. Bosserman, Christina Yeon, B. Ebrahimi, B. Emilio, G. Upadhyaya, Cary A. Presant, M. J. Vakil, F. Howard

Publikováno v: Journal of Clinical Oncology. 26:17527-17527

17527 Background: Quality of care (QC) improves when NG are followed in patient (pt) management. Demonstration of COMP with NG is costly and slow (QOPI, and ASCO 2007 abstract 17050). We extended o...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7f90a728e0e6809b427274f41ff291b
https://doi.org/10.1200/jco.2008.26.15_suppl.17527

Zobrazit plný text záznamu

Overhead costs (OC) associated with quality oncology care (QOC) monitoring to ensure compliance with national treatment guidelines (TG)

Autor: M. J. Vakil, W. McNatt, A. Der, Linda D. Bosserman, Cary A. Presant, G. Upadhyaya, R. Vakil, A. Estrella, A. Greenburg

Publikováno v: Journal of Clinical Oncology. 25:6637-6637

6637 Background: QOC is a goal of all oncology practices (op), healthcare insurance plans (hip), HMOs, and payers for health insurance. In order to ensure compliance with TG and maintain QOC in a multi-site op, we adapted an electronic medical record

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a60d9e96954284bdc3738345e6718ab4
https://doi.org/10.1200/jco.2007.25.18_suppl.6637

Zobrazit plný text záznamu

Aromatase inhibitor (AI)-associated arthralgia (A) and bone pain (BP): Frequency and characterization in clinical practice

Autor: R. C. Horns, F. Howard, Christina Yeon, A. Rios, Linda D. Bosserman, B. Ebrahimi, C. Kelly, M. J. Vakil, G. Upadhyaya, Cary A. Presant

Publikováno v: Journal of Clinical Oncology. 24:6137-6137

6137 Background: Prior studies of AI have identified A and/or BP as side effects. Reported incidences have varied from 4% (IMPACT) to 35.6% (ATAC). In order to determine the frequency of A or BP in clinical practice, we reviewed a consecutive series

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95b51ef12e0b2a5c10e3655718249b4d
https://doi.org/10.1200/jco.2006.24.18_suppl.6137

Zobrazit plný text záznamu

Heterogeneous monitoring for and management of bevacizumab (BE) toxicity (T): Develpment of standardized guidelines for monitoring (mon) and treatment (tre) of the BE toxicity syndrome (BETS)

Autor: M. J. Vakil, G. Upadhyaya, Linda D. Bosserman, C. L. Martel, Cary A. Presant, B. Ebrahimi, R. C. Horns

Publikováno v: Journal of Clinical Oncology. 23:8224-8224

8224 Background: BE is widely used for managing metastatic colorectal cancer and is in widespread trials including breast, lung, renal and lymphoid malignancies. Analysis of patients (pts) receivin...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5f17cdfad563f16066580a149ad32a4
https://doi.org/10.1200/jco.2005.23.16_suppl.8224

Zobrazit plný text záznamu

Development and implementation of effective quality (Q) guidelines (G) in community (com) cancer centers (CC): The cancer quality program (CQP)

Autor: R. C. Horns, G. Upadhyaya, M. D. Scalia, B. Ebrahimi, Christina Yeon, Linda D. Bosserman, C. L. Martel, M. J. Vakil, T. Young, Cary A. Presant

Publikováno v: Journal of Clinical Oncology. 23:6105-6105

6105 Background: National panels, institutes, and media have accused oncology of poor Q in patient (pt) care. In order to improve Q in com pt care, we developed the CQP. Methods: 8 oncologists and ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e7d40fb485fb1a38bb3ca352c47c2e6
https://doi.org/10.1200/jco.2005.23.16_suppl.6105

Zobrazit plný text záznamu

Incidence of bevacizumab (BE) related toxicities: Association of hypertension (HTN) and proteinuria (PTN), a BE toxicity syndrome (BETS)

Autor: Linda D. Bosserman, R. C. Horns, G. Upadhyaya, M. J. Vakil, Christina Yeon, Cary A. Presant, B. Ebrahimi, C. L. Martel

Publikováno v: Journal of Clinical Oncology. 23:8062-8062

8062 Background: BE, a monoclonal antibody that inhibits VEGF, prolongs survival in patients (pts) with metastatic colorectal cancer treated with 5FU chemotherapy. However, BE is associated with HT...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a132d774b4e9dce16114900546d56603
https://doi.org/10.1200/jco.2005.23.16_suppl.8062

Zobrazit plný text záznamu

Increasing accrual (Ac) to clinical trials (CT) in community cancer clinics (CCC): A successful method using electronic medical records (EMR), virtual private network (VPN) and focused group activities (FGA)

Autor: T. Young, B. Ebrahimi, M. D. Scalia, Cary A. Presant, Linda D. Bosserman, C. L. Martel, G. Upadhyaya, R. C. Horns, Christina Yeon, M. J. Vakil

Publikováno v: Journal of Clinical Oncology. 23:6088-6088

6088 Background: Patient (pt) participation in CT is below expectations. Our CCC offers CT’s through research networks, industry and investigator initiated trials and sought to maximize Ac. We used...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::06f76dc848ff04ab49f3dea9c5e5140c
https://doi.org/10.1200/jco.2005.23.16_suppl.6088

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání